Stay up to date with the latest news from DCL
Data Conversion Laboratory and Court Square Group Announce Partnership to Provide Intelligent Content Solutions to the Life Sciences Market
Improving the Clinical and Drug Development Life Cycle by Improving Content Structure, Search, and Discovery
Fresh Meadows, NY, July 8, 2020 – Data Conversion Laboratory (DCL), an industry leader in structured data and content transformations, and Court Square Group, a leading provider of Audit Ready Compliant Cloud™ (ARCC) infrastructure solutions, today announce a new partnership for global life sciences organizations. Together, DCL and Court Square Group help the pharma industry’s clinical and drug development process by providing content management and content structure solutions that support every stage of the product life cycle.
“Content structure and content management are key areas that significantly improve the speed by which advances in life sciences are communicated,” explains Jeff Wood, Chief Revenue Officer of DCL. “Intelligent content solutions that are applied to the drug development life cycle improve downstream communication and speed up the approval process.”
DCL provides content structure to documents that are critical to support the life sciences industry. For example, DCL’s structured product labeling (SPL) work comprises deconstructing forms-based content and image-based PDFs to create structured markup (XML). DCL applies a layer of metadata to facilitate downstream content discovery and delivers final SPL files to the FDA on behalf of our clients. With the latest advances in artificial intelligence and natural language processing, DCL’s content enrichment services improve content discovery for R&D applications during the development of new drugs or reclassification of pharma agents.
Together with Court Square Group, DCL’s content structure solutions help pharma and biotech companies ensure regulatory compliance and contribute to bringing products to market faster.
Court Square Group CEO and Founder, Keith Parent, explained, “DCL’s content structure expertise strongly aligns with Court Square Group’s RegDocs365 platform that manages workflows and all types of digital content and regulatory submissions in a validated and compliant environment.” Parent continued, “Partnering with DCL provides our clients with an integrated solution that addresses their content structure requirements.”
This new partnership provides pharmaceutical and biotech companies with an integrated and comprehensive solution that supports compliance to complex SPL, EDMS, eCTD, eTMF and global regulatory submissions, while working in a cloud based, validated environment that meets the requirements of 21 CFR Part 11.
Court Square Group and DCL already support customers in Europe and North America. The combined expertise delivers editorial accuracy, improved content discovery, streamlined workflows, and real-time project collaboration with all internal and external stakeholders.